Kidswell Bio Corporation Price (4584.T)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

35,344,906

(11.6595)%

Income Statement Summary

Revenue
Cost of Revenue
Gross Profit
Operating Expenses
Operating Income
Other Expenses
Net Income
news-img
Kidswell Bio Corporation
news-img

Income Statement

Kidswell Bio Corporation

Currency: JPY

YEAR 2019 2020 2021 2022 2023
Revenue
Revenue 1,077,000,000.00

+0%

996,543,000.00

-7%

1,569,231,000.00

+57%

2,776,240,000.00

+77%

2,431,235,000.00

-12%

Cost of Revenue
Cost of Revenue 654,000,000.00 119,571,000.00 550,357,000.00 1,250,553,000.00 1,391,852,000.00
Gross Profit
Gross Profit 423,000,000.00

+0%

876,972,000.00

+107%

1,018,874,000.00

+16%

1,525,687,000.00

+50%

1,039,383,000.00

-32%

Gross Profit Ratio (0.39%) (0.88%) (0.65%) (0.55%) (0.43%)
Operating Expenses
Research and Development 898,000,000.00 963,868,000.00 903,062,000.00 1,216,349,000.00 1,453,349,000.00
General and Administrative 0.00 0.00 101,902,000.00 182,930,000.00 163,963,000.00
Selling, General & Admin... 687,000,000.00 883,000,000.00 101,902,000.00 182,930,000.00 163,963,000.00
Selling & Marketing Exp... 0.00 0.00 0.00 0.00 0.00
Depreciation and Amortiz... 321,000.00 992,000.00 2,300,000.00 932,000.00 921,000.00
Other Expenses 0.00 1,719,000.00 30,873,000.00 -27,783,000.00 757,668,000.00
Total Operating Expenses 7,732,000,000.00 1,846,658,000.00 1,670,012,000.00 2,076,616,000.00 2,374,980,000.00
Cost and Exponses 8,386,000,000.00 1,966,229,000.00 2,220,369,000.00 3,327,169,000.00 3,766,832,000.00
Operating Income
Operating Income -1,162,000,000.00

+0%

-969,687,000.00

-17%

-651,139,000.00

-33%

-550,929,000.00

-15%

-1,335,597,000.00

+142%

Operating Income Ratio (-1.08%) (-0.97%) (-0.41%) (-0.20%) (-0.55%)
Other Income and Exp...
Interest Income 117,000.00 52,000.00 936,000.00 12,000.00 8,000.00
Interest Expenses 5,207,000.00 15,688,000.00 15,460,000.00 34,836,000.00 38,784,000.00
Total Other Income/Exp... -6,152,859,000.00 -29,993,000.00 101,486,000.00 -105,295,000.00 -84,930,000.00
EBITDA
EBITDA -7,308,665,999.00 -982,999,000.00 -531,893,000.00 -620,453,000.00 -1,380,821,000.00
EBITDA ratio (-1.08%) (-0.98%) (-0.40%) (-0.21%) (-0.57%)
Income Before Tax
Income Before Tax -7,314,000,000.00 -999,680,000.00 -549,653,000.00 -656,224,000.00 -1,420,527,000.00
Income Before Tax Ratio (-6.79%) (-1.00%) (-0.35%) (-0.24%) (-0.58%)
Income Tax Expense
Income Tax Expense 2,000,000.00 1,781,000.00 1,210,000.00 1,210,000.00 1,551,000.00
Net Income
Net Income -7,316,000,000.00

+0%

-1,001,461,000.00

-86%

-550,863,000.00

-45%

-657,434,000.00

+19%

-1,422,078,000.00

+116%

Net Income Ratio (-6.79%) (-1.00%) (-0.35%) (-0.24%) (-0.58%)
Earning Per Share
Basic EPS -264.64 -34.79 -17.86 -20.77 -40.23
Diluted EPS -264.64 -34.79 -17.86 -20.77 -40.23
Share Outstanding
Basic Share Outstanding 27,645,408.00 28,788,906.00 30,851,293.00 31,654,192.00 35,344,906.00
Diluted Share Outstanding 27,645,408.00 28,788,906.00 30,851,293.00 31,654,192.00 35,344,906.00
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation